bioAffinity Technologies validation trial for non-invasive lung cancer test results in high sensitivity and specificity
Trial results of automated test demonstrate non-invasive CyPath Lung is highly accurate in finding lung cancer
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jun 20
Trial results of automated test demonstrate non-invasive CyPath Lung is highly accurate in finding lung cancer
10 Jun 20
XyCAM RI allows ophthalmologists and optometrists to rapidly evaluate vascular status of the retina for enhanced disease detection…
10 Jun 20
CAREstream Group has entered into an exclusive licensing agreement with Cytonics Corporation, a biotechnology company focused on developing…
10 Jun 20
The CRO has applied its clinical assay and diagnostics capabilities to address a breadth of sponsor and employer…
10 Jun 20
CereVasc will use the proceeds from financing round to support the first-in-human clinical trial of the eShunt System
10 Jun 20
RapidAI acquires comprehensive aneurysm management innovator and expands scope to include Aneurysm, extending its leadership in cerebrovascular imaging
09 Jun 20
Thermal imaging is being used by multiple businesses as a fever-screening tool in an attempt to control the…
09 Jun 20
Phosphorus Covid-19 test is said to be only the second at-home unsupervised saliva test secured approval from the…
09 Jun 20
Edwards Lifesciences, based in Irvine, Calif., is the global leader of patient-focused medical innovations for structural heart disease…
09 Jun 20
The system has been tested in simulated lung environments and recently received Emergency Use Authorization (EUA) from the…